Literature DB >> 9192614

Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments.

C Y King1, P Tittmann, H Gross, R Gebert, M Aebi, K Wüthrich.   

Abstract

The yeast non-Mendelian genetic factor [PSI], which enhances the efficiency of tRNA-mediated nonsense suppression in Saccharomyces cerevisiae, is thought to be an abnormal cellular isoform of the Sup35 protein. Genetic studies have established that the N-terminal part of the Sup35 protein is sufficient for the genesis as well as the maintenance of [PSI]. Here we demonstrate that the N-terminal polypeptide fragment consisting of residues 2-114 of Sup35p, Sup35pN, spontaneously aggregates to form thin filaments in vitro. The filaments show a beta-sheet-type circular dichroism spectrum, exhibit increased protease resistance, and show amyloid-like optical properties. It is further shown that filament growth in freshly prepared Sup35pN solutions can be induced by seeding with a dilute suspension of preformed filaments. These results suggest that the abnormal cellular isoform of Sup35p is an amyloid-like aggregate and further indicate that seeding might be responsible for the maintenance of the [PSI] element in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192614      PMCID: PMC21207          DOI: 10.1073/pnas.94.13.6618

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB.

Authors:  J T Jarrett; P T Lansbury
Journal:  Biochemistry       Date:  1992-12-15       Impact factor: 3.162

Review 2.  The new biology of spongiform encephalopathy: infectious amyloidoses with a genetic twist.

Authors:  P Brown; L G Goldfarb; D C Gajdusek
Journal:  Lancet       Date:  1991-04-27       Impact factor: 79.321

Review 3.  Molecular biology of prion diseases.

Authors:  S B Prusiner
Journal:  Science       Date:  1991-06-14       Impact factor: 47.728

Review 4.  Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

Authors:  J T Jarrett; P T Lansbury
Journal:  Cell       Date:  1993-06-18       Impact factor: 41.582

5.  A kinetic model for amyloid formation in the prion diseases: importance of seeding.

Authors:  J H Come; P E Fraser; P T Lansbury
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

6.  Genetics. Psi no more for yeast prions.

Authors:  M F Tuite
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

7.  The SUP35 omnipotent suppressor gene is involved in the maintenance of the non-Mendelian determinant [psi+] in the yeast Saccharomyces cerevisiae.

Authors:  M D Ter-Avanesyan; A R Dagkesamanskaya; V V Kushnirov; V N Smirnov
Journal:  Genetics       Date:  1994-07       Impact factor: 4.562

8.  Multicopy SUP35 gene induces de-novo appearance of psi-like factors in the yeast Saccharomyces cerevisiae.

Authors:  Y O Chernoff; I L Derkach; S G Inge-Vechtomov
Journal:  Curr Genet       Date:  1993-09       Impact factor: 3.886

9.  Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro.

Authors:  W Colon; J W Kelly
Journal:  Biochemistry       Date:  1992-09-15       Impact factor: 3.162

10.  [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae.

Authors:  R B Wickner
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

View more
  136 in total

1.  Mutational analysis of the [Het-s] prion analog of Podospora anserina. A short N-terminal peptide allows prion propagation.

Authors:  V Coustou; C Deleu; S J Saupe; J Bégueret
Journal:  Genetics       Date:  1999-12       Impact factor: 4.562

2.  Evidence for a protein mutator in yeast: role of the Hsp70-related chaperone ssb in formation, stability, and toxicity of the [PSI] prion.

Authors:  Y O Chernoff; G P Newnam; J Kumar; K Allen; A D Zink
Journal:  Mol Cell Biol       Date:  1999-12       Impact factor: 4.272

3.  Conformational propagation with prion-like characteristics in a simple model of protein folding.

Authors:  P M Harrison; H S Chan; S B Prusiner; F E Cohen
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

4.  Dependence and independence of [PSI(+)] and [PIN(+)]: a two-prion system in yeast?

Authors:  I L Derkatch; M E Bradley; S V Masse; S P Zadorsky; G V Polozkov; S G Inge-Vechtomov; S W Liebman
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

5.  An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated beta-sheet structure for amyloid.

Authors:  M Balbirnie; R Grothe; D S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

6.  The [URE3] phenotype: evidence for a soluble prion in yeast.

Authors:  Eric Fernandez-Bellot; Elisabeth Guillemet; Frederique Ness; Agnes Baudin-Baillieu; Leslie Ripaud; Mick Tuite; Christophe Cullin
Journal:  EMBO Rep       Date:  2001-12-19       Impact factor: 8.807

7.  Two prion-inducing regions of Ure2p are nonoverlapping.

Authors:  M L Maddelein; R B Wickner
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

8.  Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+].

Authors:  Jia-Jia Liu; Neal Sondheimer; Susan L Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

9.  Prion properties of the Sup35 protein of yeast Pichia methanolica.

Authors:  V V Kushnirov; N V Kochneva-Pervukhova; M B Chechenova; N S Frolova; M D Ter-Avanesyan
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

10.  The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.

Authors:  Leslie Ripaud; Laurent Maillet; Christophe Cullin
Journal:  EMBO J       Date:  2003-10-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.